alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Cognitive Decline in 3 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellingacci, L | 2 |
| Tallarico, M | 2 |
| Mancini, A | 2 |
| Megaro, A | 2 |
| De Caro, C | 2 |
| Citraro, R | 2 |
| De Sarro, G | 2 |
| Tozzi, A | 2 |
| Di Filippo, M | 2 |
| Sciaccaluga, M | 2 |
| Russo, E | 2 |
| Leo, A | 2 |
| Costa, C | 2 |
| Lilek, J | 1 |
| Ajroud, K | 1 |
| Feldman, AZ | 1 |
| Krishnamachari, S | 1 |
| Ghourchian, S | 1 |
| Gefen, T | 1 |
| Spencer, CL | 1 |
| Kawles, A | 1 |
| Mao, Q | 1 |
| Tranovich, JF | 1 |
| Jack, CR | 1 |
| Mesulam, MM | 1 |
| Reichard, RR | 1 |
| Zhang, H | 1 |
| Murray, ME | 1 |
| Knopman, D | 1 |
| Dickson, DW | 1 |
| Petersen, RC | 1 |
| Smith, B | 1 |
| Ashe, KH | 1 |
| Mielke, MM | 1 |
| Nelson, KM | 1 |
| Flanagan, ME | 1 |
| Bhardwaj, A | 1 |
| Bhardwaj, R | 1 |
| Sharma, S | 1 |
| Sharma, SK | 1 |
| Dhawan, DK | 1 |
| Kaur, T | 1 |
3 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cognitive Decline
| Article | Year |
|---|---|
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Peptides; Animals; Cerebral A | 2023 |
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Peptides; Animals; Cerebral A | 2023 |
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Peptides; Animals; Cerebral A | 2023 |
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Peptides; Animals; Cerebral A | 2023 |
Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Brain; Cognitive Dysfun | 2023 |
AMPA induced cognitive impairment in rats: Establishing the role of endoplasmic reticulum stress inhibitor, 4-PBA.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Butylamines; Cognitive Dysfunctio | 2021 |